|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000189334 |
Summary for S100A14 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000189334 | Gene symbol | S100A14 |
| Gene name | S100 calcium binding protein A14 | |
| HGNC | 18901 | |
| Entrez ID | 57402 | |
| Gene type | protein_coding | |
| Synonyms | S100A14|S100A15|BCMP84 | |
| UniProtAcc | Q9HCY8 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for S100A14 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| S100A14 | 1.31e+04 | 3.22e+00 | 6.31e-01 | 5.11e+00 | 3.26e-07 | 2.86e-06 | BLCA |
| S100A14 | 1.09e+04 | -2.25e+00 | 3.65e-01 | -6.16e+00 | 7.41e-10 | 8.78e-09 | STAD |
| S100A14 | 1.90e+04 | 1.84e+00 | 5.73e-01 | 3.21e+00 | 1.32e-03 | 7.78e-03 | ESCA |
| S100A14 | 5.07e+03 | 3.22e+00 | 6.13e-01 | 5.25e+00 | 1.51e-07 | 1.30e-06 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| S100A14 | 1.52e+03 | 2.26e+00 | 4.45e-01 | 5.08e+00 | 3.70e-07 | 2.08e-06 | LIHC |
| S100A14 | 6.52e+02 | -2.11e+00 | 7.44e-01 | -2.84e+00 | 4.53e-03 | 8.69e-03 | KICH |
| S100A14 | 1.23e+04 | 2.63e+00 | 1.48e-01 | 1.78e+01 | 7.48e-71 | 1.35e-69 | BRCA |
Top |
Sex-biased somatic mutation for S100A14 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for S100A14 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg16348003 | chr1:153617305 | CGI:chr1:153633701-153634498 | promoter | 5.90e-01 | 7.23e-01 | -3.92e+00 | 8.78e-05 | 1.82e-04 | -1.33e-01 |
| LUAD | cg05659314 | chr1:153617544 | CGI:chr1:153633701-153634498 | promoter | 7.87e-01 | 6.81e-01 | 4.09e+00 | 4.27e-05 | 1.38e-04 | 1.06e-01 |
| LUSC | cg25433648 | chr1:153616306 | CGI:chr1:153633701-153634498 | UTR,promoter,exon,gene body | 4.71e-01 | 6.08e-01 | -2.97e+00 | 2.96e-03 | 5.54e-03 | -1.37e-01 |
| LUSC | cg05659314 | chr1:153617544 | CGI:chr1:153633701-153634498 | promoter | 8.04e-01 | 6.98e-01 | 3.18e+00 | 1.45e-03 | 3.35e-03 | 1.07e-01 |
| COAD | cg25433648 | chr1:153616306 | CGI:chr1:153633701-153634498 | UTR,promoter,exon,gene body | 3.53e-01 | 4.72e-01 | -3.62e+00 | 2.93e-04 | 8.29e-04 | -1.19e-01 |
| COAD | cg16348003 | chr1:153617305 | CGI:chr1:153633701-153634498 | promoter | 4.30e-01 | 5.76e-01 | -3.81e+00 | 1.36e-04 | 4.48e-04 | -1.46e-01 |
| BLCA | cg26010099 | chr1:153615226 | CGI:chr1:153633701-153634498 | promoter,gene body | 8.55e-01 | 9.57e-01 | -3.68e+00 | 2.34e-04 | 7.45e-04 | -1.01e-01 |
| CHOL | cg15104031 | chr1:153617052 | CGI:chr1:153633701-153634498 | promoter | 5.22e-01 | 7.10e-01 | -2.21e+00 | 2.70e-02 | 3.50e-02 | -1.88e-01 |
| CHOL | cg16348003 | chr1:153617305 | CGI:chr1:153633701-153634498 | promoter | 5.07e-01 | 6.98e-01 | -2.88e+00 | 4.04e-03 | 1.47e-02 | -1.91e-01 |
| CHOL | cg05659314 | chr1:153617544 | CGI:chr1:153633701-153634498 | promoter | 7.94e-01 | 8.96e-01 | -2.21e+00 | 2.70e-02 | 3.50e-02 | -1.02e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg26010099 | chr1:153615226 | CGI:chr1:153633701-153634498 | promoter,gene body | 8.53e-01 | 9.58e-01 | -1.03e+01 | 6.57e-25 | 5.54e-24 | -1.05e-01 |
| BRCA | cg25433648 | chr1:153616306 | CGI:chr1:153633701-153634498 | UTR,promoter,exon,gene body | 3.90e-01 | 5.78e-01 | -1.01e+01 | 3.52e-24 | 2.77e-23 | -1.87e-01 |
| BRCA | cg16348003 | chr1:153617305 | CGI:chr1:153633701-153634498 | promoter | 5.45e-01 | 6.54e-01 | -7.51e+00 | 6.05e-14 | 2.03e-13 | -1.09e-01 |
| BRCA | cg08477332 | chr1:153617767 | CGI:chr1:153633701-153634498 | promoter | 4.67e-01 | 5.89e-01 | -4.91e+00 | 8.95e-07 | 1.67e-06 | -1.22e-01 |
| HNSC | cg25433648 | chr1:153616306 | CGI:chr1:153633701-153634498 | UTR,promoter,exon,gene body | 4.69e-01 | 3.64e-01 | 2.05e+00 | 4.06e-02 | 4.32e-02 | 1.05e-01 |
| HNSC | cg13098855 | chr1:153616451 | CGI:chr1:153633701-153634498 | promoter,gene body | 4.70e-01 | 3.51e-01 | 2.24e+00 | 2.51e-02 | 3.17e-02 | 1.19e-01 |
| HNSC | cg15104031 | chr1:153617052 | CGI:chr1:153633701-153634498 | promoter | 4.92e-01 | 3.71e-01 | 2.67e+00 | 7.60e-03 | 1.62e-02 | 1.21e-01 |
Top |
Exon skipping events with PSI in TCGA for S100A14 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for S100A14 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for S100A14 |
TFs related to S100A14.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
S100A14 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for S100A14 |
RBPs related to ES in S100A14.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| COAD | SAMD4A | exon_skip_31508 | 8.87e+00 | 9.92e-01 | 8.44e+00 | 3.65e-03 | Male-biased |
| LUAD | SRSF9 | exon_skip_31467 | 6.86e+00 | 9.82e-01 | 6.40e+00 | 2.63e-03 | Male-biased |
| CHOL | SAMD4A | exon_skip_31508 | 8.74e+00 | 9.84e-01 | 8.34e+00 | 1.02e-02 | Male-biased |
| BRCA | SAMD4A | exon_skip_31508 | 8.51e+00 | 7.31e-04 | 1.01e+01 | 9.97e-01 | Female-biased |
| ESCA | SAMD4A | exon_skip_31508 | 9.13e+00 | 9.94e-01 | 8.50e+00 | 2.86e-03 | Male-biased |
| READ | SAMD4A | exon_skip_31508 | 8.98e+00 | 9.94e-01 | 8.45e+00 | 1.35e-03 | Male-biased |
S100A14 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs12409375 | chr1:159863943:C:T | - | 0.299702145541325 | 0.010795083188155 | PAAD | Female-baised eQTL |
| rs3795332 | chr1:159864638:T:G | - | 0.299702145541325 | 0.010795083188155 | PAAD | Female-baised eQTL |
| rs60881685 | chr1:159861471:G:A | - | 0.275537649740667 | 0.026234073708702 | PAAD | Female-baised eQTL |
| rs74124737 | chr1:159863012:A:C | - | 0.275537649740667 | 0.026234073708702 | PAAD | Female-baised eQTL |
| rs6658946 | chr1:159863198:T:C | - | 0.275537649740667 | 0.026234073708702 | PAAD | Female-baised eQTL |
| rs6692820 | chr1:159863471:C:T | - | 0.275537649740667 | 0.026234073708702 | PAAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg16348003 | chr1:153617305 | promoter | -0.426670826192277 | 2.92197005043104e-08 | -0.5990762206323033 | 7.199248314512171e-11 | PAAD |
| cg13098855 | chr1:153616451 | gene,promoter | -0.266395502394095 | 5.845903408498e-06 | -0.5301348936540545 | 1.978500396907619e-08 | PAAD |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg16348003 | chr1:153617305 | promoter | -0.485678568693436 | 4.51146689823233e-17 | -0.8473618163208716 | 3.3654572256186575e-21 | KIRP |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of S100A14 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |